Necrotizing Enterocolitis Clinical Trial
Official title:
Efficacy Of Oral Melatonin To Prevent Necrotizing Enterocolitis Among Preterm Infants In A Tertiary Level Hospital In The Philippines: A Randomized Control Trial
Verified date | June 2024 |
Source | Ilocos Training and Regional Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Prematurity is still one of the primary causes of death in children under 5. 1-2. According to the WHO, 60% of all preterm births occur in Asia, with the Philippines accounting for around 348,900 every year. 3. Necrotizing enterocolitis is one of the fatal complications (NEC) 3, 4. Preterm newborns weighing 1500 grams or less are considered high risk. 5-6. Melatonin is one chemical that may help prevent NEC. Melatonin is an endogenous indolamine derived from serotonin. It is a ubiquitous molecule that is crucial to the body's physiologic function. Melatonin, also known as N-acetyl-5-methoxytryptamine, is an immunomodulator, antioxidant, anti-inflammatory, and free radical scavenger7-10. It is a naturally occurring chemical that is simply replenished. With this in mind, the researcher wants to see if providing high dose melatonin to premature babies can prevent NEC.
Status | Completed |
Enrollment | 100 |
Est. completion date | December 31, 2021 |
Est. primary completion date | December 31, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 28 Weeks to 36 Weeks |
Eligibility | Inclusion Criteria: - 1. Newborn with a pediatric age of less than 37 weeks categorized very preterm (28 to 32 weeks) and late preterm (32 to 36weeks) by the World Health Organization weighing not more than 1500. 2. Preterm infants admitted at the Neonatal Intensive care unit of Ilocos Training Regional and Medical Center not more than 24 hours of age. 3. Preterm infants with orogastric tube in place. 4. Preterm infants with no other condition other than prematurity and respiratory distress syndrome. 5. Preterm infant with an Apgar score of more than 6 in the first minute of life. Exclusion Criteria: 1. Preterm infants more than 1 day of life. 2. Preterm infants diagnosed with NEC 3. Preterm infants who is born to a mother of who considered as a minor (<18 years old) and is not married to the father of the unborn child. 4. Preterm infants that could not be fed through oral gastric tube due to a secondary problem. 5. Preterm infants with other comorbidities such as asphyxia, congenital anomalies, and other inherited disorders. 6. Meconium Stained Preterm infants - |
Country | Name | City | State |
---|---|---|---|
Philippines | Ilocos Training and Regional Medical Center | San Fernando | LA Union |
Lead Sponsor | Collaborator |
---|---|
Ilocos Training and Regional Medical Center | Vayu Global Foundation |
Philippines,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number Of Preterm Infants Who Developed Necrotizing Enterocolits After Melatonin 6mg Tablet Prophylaxis | effectiveness of melatonin in preventing NEC among preterm infants with a birthweight of = 1500 kg at Ilocos Training and Regional Medical Center. | 5 MONTHS | |
Secondary | Incidence of Prematurity at Training and Regional Medical Center | Clinical Profiles Of Preterm Infants Born In Ilocos Training and Regional Medical Center | 5 MONTHS | |
Secondary | Number of Patients Who Developed Abnormal Gas Pattern with Dilated Bowel Loops after Melatonin 6mg Tablet Prophylaxis | Absence of Clinical And Radiologic Findings Diagnostic of Necrotizing Enterocolitis. | 5 MONTHS | |
Secondary | Number of Patients Who Developed Pneumatosis intestinalis after Melatonin 6mg Tablet Prophylaxis | Absence of Clinical And Radiologic Findings Diagnostic of Necrotizing Enterocolitis. | 5 Months | |
Secondary | Number of Patients Who Developed Sentinel Loops after Melatonin 6mg Tablet Prophylaxis | Absence of Clinical And Radiologic Findings Diagnostic of Necrotizing Enterocolitis. | 5 Months | |
Secondary | Number of Patients Who Developed Portal Venous Gas after Melatonin 6mg Tablet Prophylaxis | Absence of Clinical And Radiologic Findings Diagnostic of Necrotizing Enterocolitis. | 5 Months | |
Secondary | Number Of Hospital Days Among Preterm Infants Admitted at Ilocos Training and Regional Medical Center | Efficacy of Melatonin Oral Prophylaxis | 5 Months | |
Secondary | Number Of Days Before Oral FeedingAmong Preterm Infants Admitted at Ilocos Training and Regional Medical Center | Efficacy of Melatonin Oral Prophylaxis | 5 motnhs |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05544097 -
Spectral Analysis of Bowel Sounds in Preterm Babies of Less Than 32 Weeks of Amenorrhea (WA) as Predictive Factor of Enterocolitis
|
N/A | |
Recruiting |
NCT03210831 -
Early Predictors of Necrotizing Enterocolitis in Neonates
|
||
Not yet recruiting |
NCT06045130 -
PUFAs in Preterm Infants
|
||
Recruiting |
NCT02552706 -
The Efficacy and Mechanisms of Oral Probiotics in Preventing Necrotizing Enterocolitis
|
N/A | |
Completed |
NCT02400697 -
Placental Transfusion Project for Preterm Infants
|
N/A | |
Completed |
NCT01751477 -
Infloran® for Prevention of Necrotizing Enterocolitis
|
N/A | |
Terminated |
NCT01156480 -
Anti-inflammatory Treatment at the Onset of Necrotizing Enterocolitis (NEC) in Preterm Infants
|
N/A | |
Completed |
NCT00787124 -
Transfusions and Nitric Oxide Level in Preterm Infants
|
||
Unknown status |
NCT00254176 -
Cysteine Supplementation in Critically Ill Neonates
|
Phase 2/Phase 3 | |
Recruiting |
NCT01441739 -
Intestinal Failure in Necrotising Enterocolitis
|
N/A | |
Recruiting |
NCT03869827 -
Necrotizing Enterocolitis in Fetuses With Intrauterine Growth Restriction
|
||
Recruiting |
NCT04074824 -
A Genome-Wide Association Study for Neonatal Diseases
|
||
Terminated |
NCT03320785 -
Circulating Markers in Preterm Infants With Perinatal and Neonatal Inflammation
|
||
Active, not recruiting |
NCT03554278 -
Alteration of Stool Microbiota in Preterm Infants With Anemia
|
||
Not yet recruiting |
NCT04541771 -
The Role of Lactobacillus Reuteri in Preventing Necrotizing Enterocolitis (NEC) in Pre-term Infants
|
Phase 2 | |
Not yet recruiting |
NCT03700957 -
The Impact of Docosahexaenoic Acid on the Prevention of Necrotizing Enterocolitis in Preterm Neonates
|
N/A | |
Completed |
NCT03551600 -
Splanchnic and Renal Tissue Oxygenation During Enteral Feedings in Neonates With Patent Ductus Arteriosus
|
||
Completed |
NCT01735578 -
Splanchnic Tissue Oxygenation During Enteral Feedings in Anemic Premature Infants at Risk for Necrotizing Enterocolitis
|
N/A | |
Completed |
NCT01745510 -
Enteral Administration of Docosahexaenoic Acid to Prevent Necrotizing Enterocolitis in Preterm Neonates
|
Phase 1/Phase 2 | |
Unknown status |
NCT01807858 -
The Effects of Synbiotics on Morbidity and Mortality in Preterm Infants
|
N/A |